← FDA DRUG APPROVALS

FDA ANDA · ANDA073376

MORPHINE SULFATE

Sponsor: WATSON LABS

APPLICATION
ANDA073376
TYPE
ANDA
ORIGINAL APPROVAL
1991-09-30
LATEST ACTION
1999-03-12
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MORPHINE SULFATEDiscontinued
MORPHINE SULFATE 1MG/ML · INJECTABLE · INJECTION

Approval history

1999-03-12Manufacturing (CMC) · Supplement 3AP
1999-02-19Manufacturing (CMC) · Supplement 4AP
1999-02-02Manufacturing (CMC) · Supplement 2AP
1997-03-19Manufacturing (CMC) · Supplement 1AP
1991-09-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →